Skip to main content

Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma

Publication ,  Journal Article
Amano, Y; Yamaguchi, K; Mandai, M; Matsumura, N; Hamanishi, J; Baba, T; Yamanoi, K; Murphy, SK; Konishi, I
Published in: Clinical Cancer Research
October 1, 2013

Ovarian clear cell carcinoma (OCCC) is a histologic subtype of epithelial ovarian cancer (EOC) with unique characteristics including chemoresistance and carcinogenic origins from endometriotic cysts. We previously reported that a high concentration of free iron in endometriotic cysts causes oxidative stress. (Yamaguchi K, Clin Can Res, 2008). We also reported that resistance to oxidative stress is an inherent characteristic of OCCC, and that HNF1β pathway genes are upregulated exclusively in OCCC relative to the other EOCs (Yamaguchi K, Oncogene, 2010). Recent findings indicate that cancer cell-specific metabolism (the Warburg effect) confers resistance to oxidative stress by suppressing the mitochondrial TCA cycle, thus leading to decreased production of intracellular reactive oxygen species (ROS). The aim of this study was to verify our hypothesis that HNF1β mediates resistance to oxidative stress in OCCC through the cancer-specific metabolic process.Expression of HNF1β in RMGII and JHOC5 OCCC cell lines was repressed using two different shRNAs, sh1-HNF1β and sh2-HNF1β. HNF1β knockdown was associated with increased sensitivity (reduced IC50) to ferric nitrilotriacetate (Fe-NTA; a Fe-mediated inducer of oxidative stress), and increased intracellular ROS (p<0.05 for both cell lines). Comprehensive metabolomic analyses using capillary electrophoresis time-of-flight mass spectrometry was used in RMGII cells to compare HNF1β knockdown to controls. Knockdown of HNF1β was associated with decreased intracellular lactic acid (p<0.05), increased pyruvic acid (p<0.01) and increased citric acid (p<0.01), indicating that HNF1β increases anaerobic glycolysis while suppressing the TCA cycle, consistent with the Warburg effect. Glutathione, another major antioxidant molecule, was significantly decreased in the HFN1β knockdown cells (p<0.0005). A quantitative intracellular glutathione assay confirmed that intracellular glutathione was decreased by HNF1β knockdown in both cell lines (p<0.05, respectively).We analyzed gene expression microarray data (Affymetrix U133 plus 2) for sh1-HNF1β-RMGII (n=5), sh2-HNF1β-RMGII (n=5) and sh-control-RMGII (n=10) cells. Of the genes encoding key molecules involved in glutathione biosynthesis such as cystine transporters (SLC3A1 and SLC7A9) and biosynthesis enzymes (GSS, GCLC and GCLM), only SLC3A1 transcription was significantly downregulated by HNF1β knockdown (p<0.0001). Western blots showed that SLC3A1 protein expression was also downregulated by knockdown of HNF1β in both RMGII and JHOC5 cells. Furthermore, from analysis of microarray dataset GSE39204, HNF1β and SLC3A1 expression are positively correlated in clinical ovarian cancer specimens (p<0.0001).In summary, we found HNF1β, exclusively expressed in OCCC, confers resistance to Fe-mediated oxidative stress which is abundant in endometriotic cysts, the precursor lesion of OCCC. This may be mechanistically driven by decreased TCA cycle activity combined with increased intracellular glutathione through increased expression of cystine transporter SLC3A1. Further investigation of this mechanism may lead to development of new therapeutic modalities against OCCC.This abstract is also presented as Poster B37.Citation Format: Yasuaki Amano, Ken Yamaguchi, Masaki Mandai, Noriomi Matsumura, Junzo Hamanishi, Tsukasa Baba, Koji Yamanoi, Susan K. Murphy, Ikuo Konishi. HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian Cancer Research: From Concept to Clinic; Sep 18-21, 2013; Miami, FL. Philadelphia (PA): AACR; Clin Cancer Res 2013;19(19 Suppl):Abstract nr PR08.

Duke Scholars

Published In

Clinical Cancer Research

DOI

EISSN

1557-3265

ISSN

1078-0432

Publication Date

October 1, 2013

Volume

19

Issue

19_Supplement

Start / End Page

PR08 / PR08

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Amano, Y., Yamaguchi, K., Mandai, M., Matsumura, N., Hamanishi, J., Baba, T., … Konishi, I. (2013). Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma. Clinical Cancer Research, 19(19_Supplement), PR08–PR08. https://doi.org/10.1158/1078-0432.ovca13-pr08
Amano, Yasuaki, Ken Yamaguchi, Masaki Mandai, Noriomi Matsumura, Junzo Hamanishi, Tsukasa Baba, Koji Yamanoi, Susan K. Murphy, and Ikuo Konishi. “Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma.” Clinical Cancer Research 19, no. 19_Supplement (October 1, 2013): PR08–PR08. https://doi.org/10.1158/1078-0432.ovca13-pr08.
Amano Y, Yamaguchi K, Mandai M, Matsumura N, Hamanishi J, Baba T, et al. Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma. Clinical Cancer Research. 2013 Oct 1;19(19_Supplement):PR08–PR08.
Amano, Yasuaki, et al. “Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma.” Clinical Cancer Research, vol. 19, no. 19_Supplement, American Association for Cancer Research (AACR), Oct. 2013, pp. PR08–PR08. Crossref, doi:10.1158/1078-0432.ovca13-pr08.
Amano Y, Yamaguchi K, Mandai M, Matsumura N, Hamanishi J, Baba T, Yamanoi K, Murphy SK, Konishi I. Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma. Clinical Cancer Research. American Association for Cancer Research (AACR); 2013 Oct 1;19(19_Supplement):PR08–PR08.

Published In

Clinical Cancer Research

DOI

EISSN

1557-3265

ISSN

1078-0432

Publication Date

October 1, 2013

Volume

19

Issue

19_Supplement

Start / End Page

PR08 / PR08

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis